Charles River Laboratories International, Inc. Common Stock · Transaction May 15, 2025 · Filed May 31, 2025 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · CRL
+1.17% · +$3.36 · Vol 445.7K
After hours · updated 19:00:00 ET
Charles River Laboratories International Inc
Life Sciences Tools & Services
$290.19
Follow $CRL
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $CRL by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredFri Oct 2 · session closed · Markets closed · resumes Mon 9:30 ET · CRL
MethodologyCRL
Charles River Laboratories International Inc
Fri Oct 2 · session closed · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
67/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Oct 2 · session closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is CRL moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Charles River Laboratories International Inc
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHFounded
1947
Listed
2000
Employees
20K
Country
US
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$287.91
Day high
$290.61
Day low
$285.75
Previous close
$286.83
52W high
$298.58
-2.81% from high
52W low
$149.93
94% of range
Market cap
$13.7B
P/E
158.57×
EPS
$1.83
Beta
0.78
Shares out
47.7M
Volume
445.7K
0.48× rel vol
Avg volume
920.1K
VWAP
$289.04
Price history computed in-house
1W
-0.90%
1M
-0.54%
3M
+25.79%
1Y
+65.48%
YTD
+45.47%
SMA 50 $276.07 · above
SMA 200 $209.97 · above
52W position 94%
CRL overview
Related filings and maps
Public disclosures
Congress activity in CRL
Official filing ↗
Jefferson ShreveSell
Charles River Laboratories International, Inc. Common Stock · Transaction May 12, 2025 · Filed Jun 22, 2025 · $15,001 to $50,000
Charles River Laboratories International, Inc. Common Stock · Transaction May 8, 2025 · Filed Jun 22, 2025 · $15,001 to $50,000
Charles River Laboratories International, Inc. Common Stock · Transaction Apr 8, 2025 · Filed May 8, 2025 · $15,001 to $50,000
Charles River Laboratories International, Inc. Common Stock · Transaction Jan 15, 2025 · Filed Feb 12, 2025 · $1,001 to $15,000
Federal contracts
CRL contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRL in this window.
Lobbying spend
CRL lobbying filings, year to date.
Registered lobbying filings matched to Charles River Laboratories International Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CRL in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for CRL.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.